EV/EBITDA
119.71
-2.16-1.77%
Mon, 10 Mar 2025 09:00:51 GMT
Summary
- As of March 10, 2025, TGTX EV/EBITDA is 119.71, with a fall of -2.16 (-1.77%) during the most recent trading day.
- Over the past year, TGTX EV/EBITDA has increased by +18.98 (+18.84%).
- TGTX EV/EBITDA is now -87.24% below its all-time high of 937.93.
Performance
TGTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TGTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.8% | -1.8% | -1.8% |
| 1 m1 month | +17.6% | +17.6% | +17.0% |
| 3 m3 months | -85.7% | +20.0% | +18.8% |
| 6 m6 months | +254.3% | +63.3% | +60.3% |
| ytdytd | +26.1% | +26.1% | +25.5% |
| 1 y1 year | +18.8% | +127.8% | +122.7% |
| 5 y5 years | +1847.6% | +422.7% | +238.4% |
TGTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.8% | 91.26 | +31.2% | |
| 3 m | 3-month | 917.27 | -87.0% | 88.47 | +35.3% |
| 6 m | 6-month | 937.93 | -87.2% | 32.79 | +265.1% |
| 1 y | 1-year | 937.93 | -87.2% | 25.37 | +371.9% |
| 3 y | 3-year | 937.93 | -87.2% | -74.07 | +261.6% |
| 5 y | 5-year | 937.93 | -87.2% | -74.07 | +261.6% |
| alltime | all time | 937.93 | -87.2% | -74.07 | +261.6% |
TG Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 119.71(+26.1%) |
| 2024 | 94.92(-4.7%) |
| 2023 | 99.60(-1338.8%) |
| 2022 | -8.04(+9.8%) |
| 2021 | -7.32(-70.6%) |
| 2020 | -24.94(+265.2%) |
| 2019 | -6.83(+290.3%) |
| 2018 | -1.75(-62.2%) |
| Date | Value |
|---|---|
| 2017 | -4.63(+52.8%) |
| 2016 | -3.03(-67.6%) |
| 2015 | -9.34(-20.7%) |
| 2014 | -11.78(+144.9%) |
| 2013 | -4.81(+48.9%) |
| 2012 | -3.23(>+9900.0%) |
| 2011 | -0.01(-99.8%) |
| 2010 | -5.30 |
FAQ
- What is TG Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for TG Therapeutics?
- What is TGTX EV/EBITDA year-to-date change?
- What is TG Therapeutics EV/EBITDA year-on-year change?
What is TG Therapeutics EV/EBITDA?
The current EV/EBITDA of TGTX is 119.71
What is the all time high EV/EBITDA for TG Therapeutics?
TG Therapeutics all-time high EV/EBITDA is 937.93
What is TGTX EV/EBITDA year-to-date change?
TG Therapeutics EV/EBITDA has changed by +24.79 (+26.12%) since the beginning of the year
What is TG Therapeutics EV/EBITDA year-on-year change?
Over the past year, TGTX EV/EBITDA has changed by +18.98 (+18.84%)